Below is Validea's guru fundamental report for IOVANCE BIOTHERAPEUTICS INC (IOVA). Of the 22 guru strategies we follow, IOVA rates highest using our Value Investor model based on the published ...

In trading on Monday, shares of Iovance Biotherapeutics Inc (Symbol: IOVA) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $5.52 per share.

Pictured is an Inova Saville mobile cancer screening clinic.(Courtesy Inova Saville Cancer Prevention Center) Early detection of cancer saves lives — this week, the Inova Schar Cancer Institute ...

In a report released today, Joseph Catanzaro from Piper Sandler maintained a Hold rating on Iovance Biotherapeutics (IOVA – Research Report), with a price target of $7.50. The company’s shares ...

Truist Financial analyst Asthika Goonewardene maintained a Buy rating on Iovance Biotherapeutics (IOVA – Research Report) today. The company’s shares closed yesterday at $5.78. Discover ...

In this article, we are going to take a look at where Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) stands against other Billionaire Joseph Edelman’s long-term stock picks. Joseph Edelman is a ...

Kanadevia Inova, formerly Hitachi Zosen Inova, has acquired UK-based Iona Capital (ICL), along with a portfolio of 11 renewable gas plants in the UK and a pipeline of projects globally. Kanadevia ...

SG Americas Securities LLC purchased a new position in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) in the 4th quarter, Holdings Channel.com reports.The fund purchased ...

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) shares hit a new 52-week low during trading on Monday after Piper Sandler lowered their price target on the stock from $10.00 to $7.50.

Leaders at Inova Loudoun Hospital cut the ribbon Friday on a 42,000-square-foot space for new children’s and medical units. It’s a $30 million project they hope will make hospital stays feel a ...

In this article, we are going to take a look at where Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) stands against other Billionaire Joseph Edelman’s long-term stock picks. Joseph Edelman is a renowned ...

IOVA Price Action: Iovance shares were down 8.28% at $6.58 at the time of writing, according to Benzinga Pro.